| Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629) |
|---|
| 02/24/2010 | EP2155862A2 Ex vivo expansion of human hematopoietic stem cells |
| 02/24/2010 | EP2155861A1 Patient-specific stem cell lines derived from human parthenogenetic blastocysts |
| 02/24/2010 | EP2155860A1 Multipotent stem cells and uses thereof |
| 02/24/2010 | EP2155859A1 Formulations and methods for culturing embryonic stem cells |
| 02/24/2010 | EP2155858A1 Cell construct, its process of manufacture, as well as a device, implant and processes for the mechanical stimulation of cells in vitro and in vivo |
| 02/24/2010 | EP2155857A1 Slicing device |
| 02/24/2010 | EP2155206A1 Wound and cutaneous injury healing with a nucleic acid encoding a proteoglycan polypeptide |
| 02/24/2010 | EP1801199B1 Cell-releasing agent, method of releasing cell sheet and use of cell-releasing agent |
| 02/24/2010 | EP1725267B1 Enzyme-prodrug therapy for prosthetic joint repair |
| 02/24/2010 | EP1485481B1 Fluorescent protein from aequorea coerulescens and uses thereof |
| 02/24/2010 | EP1325130B1 Nogo receptor homologs |
| 02/24/2010 | EP1200607B1 Tet repressor-based transcriptional regulatory proteins |
| 02/24/2010 | EP1185621B1 Surface for cell culture |
| 02/24/2010 | EP0861261B9 Nucleotide and protein sequences of vertebrate delta genes and methods based thereon |
| 02/24/2010 | CN101657536A Method for preparation of cartilage cell |
| 02/24/2010 | CN101657535A Pluripotent cells from rat and other species |
| 02/24/2010 | CN101657206A Treatment of inflammatory diseases using placental stem cells |
| 02/24/2010 | CN101654673A Rna interference mediating small rna molecules |
| 02/24/2010 | CN101654672A Rna interference mediating small rna molecules |
| 02/24/2010 | CN101654668A Hybridoma cell line and monoclonal antibody for producing angiostrongylus cantonensis V-stage larvae 55KD antigen |
| 02/24/2010 | CN101654483A compositions and methods for generating chimeric heteromultimers |
| 02/24/2010 | CN101654479A Mammalian receptor proteins, agents, and methods relating thereto |
| 02/24/2010 | CN100591772C Non-linear amplitude dielectrophoresis waveform for cell fusion |
| 02/24/2010 | CN100591769C Regulated nucleic acid expression system |
| 02/24/2010 | CN100591762C Antigen presenting cells, method for their preparation and their use for cancer vaccines |
| 02/24/2010 | CN100591761C Preparation of antigen-presenting human gamma delta t cells and use in immunotherapy |
| 02/24/2010 | CN100591760C Process for producing cytotoxic lymphocyte |
| 02/24/2010 | CN100591759C Animal protein free media for cultivation of cells |
| 02/23/2010 | US7667114 Starch branching enzyme |
| 02/23/2010 | US7667113 Plants and seeds of hybrid corn variety CH934397 |
| 02/23/2010 | US7667112 Plants and seeds of corn variety CV267821 |
| 02/23/2010 | US7667111 Plants and seeds of corn variety CV485971 |
| 02/23/2010 | US7667110 Plants and seeds of corn variety CV935311 |
| 02/23/2010 | US7667109 Plants and seeds of corn variety CV407125 |
| 02/23/2010 | US7667108 Inbred corn line G07-NPFA7278 |
| 02/23/2010 | US7667101 Watermelon line 110-1005 |
| 02/23/2010 | US7667100 Expression vector comprising nucleotide sequences coding which confer a tolerant phenotype in plants in response to chronic and/or acute inhibitin dosages of auxinic herbicides |
| 02/23/2010 | US7667099 Comprises expression vectors coding accumulation and replication of chloroplast (ARC) polypeptides for altering size, morphhology and number of plastids in crop plants |
| 02/23/2010 | US7667097 Rice pollen-preferential promoters and uses thereof |
| 02/23/2010 | US7667094 for plant cells; protein kinases |
| 02/23/2010 | US7667021 Neutralizing human anti-IGFR antibody |
| 02/23/2010 | US7667019 Flea ultraspiracle nucleic acid molecules |
| 02/23/2010 | US7667018 A gene (designated 161P2F10B) and its encoded protein which exhibits tissue specific expression in normal adult tissue and is aberrantly expressed in the cancers; medical diagnostis;, prognosis, prophylactis and/or gene therapy; tissue-target therapy; used to elicit a humoral or cellular immune response |
| 02/23/2010 | US7667016 nucleic acid compositions encoding a unique colorless protein, can be photoactivated, used in many biochemical, molecular biological and medical diagnostic applications |
| 02/23/2010 | US7667015 Genetic engineering; induce immunology response; biodrug as anticarcinogenic agents, for pancreatic cancer |
| 02/23/2010 | US7667013 Gene encoding a guanine nucleotide exchange factor and the gene product thereof |
| 02/23/2010 | US7667012 Condensation of a specifically engineered phosphine containing a cleavable linker so that a substituent of the phosphine is transferred to the azide, releasing an oxidized phosphine by-product and producing an amide bond in final product; N-azidogalactosamine |
| 02/23/2010 | US7667008 Heparin binding protein for use in controlling angiogenesis and as wound healing agent |
| 02/23/2010 | US7667006 Anti-HIV antibody |
| 02/23/2010 | US7667000 Antibodies to Zcytor 16 |
| 02/23/2010 | US7666999 Neutral amino acid transporter and gene thereof |
| 02/23/2010 | US7666995 Interferons, uses and compositions related thereto |
| 02/23/2010 | US7666994 fusion protein comprising isolated GnRH receptor protein; culturing transformant comprising vector; screening for ligands; cancer and reproductive treatment |
| 02/23/2010 | US7666993 Immunotherapy of prostate, including hormone-refractory prostate cancer (HRPC), and breast cancer; vaccines |
| 02/23/2010 | US7666839 Methods of treatment using specific binding agents of human angiopoietin-2 |
| 02/23/2010 | US7666832 Administering peptibodies, i.e., peptides fused to other molecules such as an Fc domain of an antibody, where the peptide moiety specifically binds to Ang-2 ( angiopoietin-2); antiinflammatory agent; antirheumatic agent |
| 02/23/2010 | US7666831 Administering peptibodies, i.e., peptides fused to other molecules such as an Fc domain of an antibody, where the peptide moiety specifically binds to Ang-2 ( angiopoietin-2); antiinflammatory agent; antirheumatic agent |
| 02/23/2010 | US7666678 Proteins imparting boron-tolerance and genes thereof |
| 02/23/2010 | US7666676 inhibiting expression of SHh in primitive neuroectodermal tumor cells via transfecting tumor cells with siRNA primer pair consisting of antisense shh gene sequences; hedgehog pathway; antiproliferative agents |
| 02/23/2010 | US7666675 Hair follicle stem cells for use in the treatment of nervous system disorders and cell therapy |
| 02/23/2010 | US7666674 Use of sterically stabilized cationic liposomes to efficiently deliver CPG oligonucleotides in vivo |
| 02/23/2010 | US7666673 Method of growing sperm stem cells in vitro, sperm stem cells grown by the method, and medium additive kit to be used in growing sperm stem cells in vitro |
| 02/23/2010 | US7666672 Neural stem cell culture for prevention and treatment of brain and nervous sytem disorders |
| 02/23/2010 | US7666671 tape impregnated with inactivated fixative, which is removed from slide after fixative is activated |
| 02/23/2010 | US7666670 Animal model for the fast identification of pharmaceutical active compounds in vivo |
| 02/23/2010 | US7666651 Polypeptide having heparanase activity |
| 02/23/2010 | US7666644 Glyphosate acetylating enzyme for use in generating and/or enhancing herbicide resistance in plants; biological pest control |
| 02/23/2010 | US7666643 Recombinant polypeptide for confering glyphosate resistance to crops; herbicide resistant plants |
| 02/23/2010 | US7666639 Plant deoxyribonucleoside kinase enzymes and their use |
| 02/23/2010 | US7666633 Enzymes having alpha amylase activity and methods of making and using them |
| 02/23/2010 | US7666632 Preparing alternan and/or fructose, wherein a saccharose-containing solution is contacted with an alternansucrase protein under conditions permitting the conversion of saccharose into alternan and/or fructose, wherein the protein is encoded by a nucleic acid molecule |
| 02/23/2010 | US7666629 Trypsinogen protein for use as tool in polypeptide analysis |
| 02/23/2010 | US7666626 P4 variant protein that has reduced enzymatic activity and that induces antibody to wild-type P4 protein and/or has good bactericidal activity against non-typable H. influenzae (NTHi) |
| 02/23/2010 | US7666624 Chemically conjugating a peptide of interest to a heterologous peptide that has been expressed on the coat protein of a cowpea mosaic virus to generate a conjugate and administering the conjugate to a host animal to increase the level of TH1-type immune response |
| 02/23/2010 | US7666623 Method for producing alpha-1, 6-branched alpha-1, 4-glucans from sucrose |
| 02/23/2010 | US7666622 Nucleic acid encoding monomeric fusion polypeptide R1-M-L-M, wherein R1 is a ligand-binding domain of an interleukin receptor capable of binding an interleukin target ligand, M is a self-associating component, and L is a linker; therapy for cancer or diabetic retinopathy |
| 02/23/2010 | US7666621 Has an apparent molecular weight of 42,000 Daltons; fusion protein of the protein D bound to a polypeptide, carbohydrate, or matrix; prepared by providing a non-human host containing a plasmid or phage comprising a DNA nucleotide sequence and expressing the encoded protein D |
| 02/23/2010 | US7666433 Recombinant RSV strains with altered G protein |
| 02/23/2010 | US7666422 Methods for the treatment of cancer using anti-CD40 antibodies |
| 02/23/2010 | US7666416 Mammalian cell culture process |
| 02/23/2010 | US7666415 Production and use of novel peptide-based agents for use with bi-specific antibodies |
| 02/23/2010 | US7666405 Deleted adenovirus vectors and methods of making and administering the same |
| 02/23/2010 | US7666401 Compositions comprising a ligand of Chemerin R |
| 02/23/2010 | CA2416949C Non-human animal model unresponsive to mycoplasma derived lipoprotein/lipopeptide |
| 02/23/2010 | CA2389743C Recombinant sendai virus vector for introducing exogenous genes to airway epithelia |
| 02/23/2010 | CA2355834C Human akt-3 |
| 02/23/2010 | CA2315277C Pharmaceutical compositions containing the long pentraxin ptx3 |
| 02/23/2010 | CA2161958C Method and apparatus for semi-automated cell separation |
| 02/23/2010 | CA2138999C Cloning and expression of gonadotropin-releasing hormone receptor |
| 02/23/2010 | CA2125449C Vector and mammalian cell line having improved productivity |
| 02/18/2010 | WO2010019886A1 Purified mesenchymal stem cell compositions and methods of purifying mesenchymal stem cell compositions |
| 02/18/2010 | WO2010019838A2 Stress tolerant transgenic crop plants |
| 02/18/2010 | WO2010019487A1 Improved vectors and yeast strains for protein production: ca2+ atpase overexpression |
| 02/18/2010 | WO2010019016A2 Composition for preventing or treating liver diseases, containing plant stem cell lines derived from the cambium of panax ginseng including mountain ginseng or ginseng as active ingredient |
| 02/18/2010 | WO2010018996A2 Human neural stem cell, and pharmaceutical composition for the treatment of central or peripheral nervous system disorders and injuries using same |
| 02/18/2010 | WO2010018847A1 Recombinant protein-s composition |
| 02/18/2010 | WO2010018598A1 Hybrid-type histidine kinase gene isolated from indica rice ir64 |
| 02/18/2010 | WO2010018297A1 Use of catecholamine for differentiation of stem cells into cardiomyocytes |
| 02/18/2010 | WO2010017983A1 Clastogenicity testing |
| 02/18/2010 | WO2010017962A1 Modified thromboxane a2 receptor promoter sequence |